Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adipic Acid SCHEMBL5395454 | 0.95 | LMNA (0.55) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Glutarate SCHEMBL27824860 | 0.74 | SLC22A6 (0.85) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Glutarate SCHEMBL158774 | 0.74 | SLC22A6 (1.00) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Glutarate SCHEMBL7414 | 0.74 | — | — | |
| Glutarate SCHEMBL6701735 | 0.74 | — | — | |
| Glutarate SCHEMBL27601182 | 0.74 | SLC22A6 (1.00) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Glutarate SCHEMBL250428 | 0.72 | FFAR1 (0.61) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Terephthalic Acid SCHEMBL8815351 | 0.72 | TSHR (0.63) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Glutarate SCHEMBL5603986 | 0.71 | SLC22A6 (0.92) | SLC22A6LMNAHDAC3HDAC4HDAC1 | |
| Glutarate SCHEMBL106538 | 0.71 | SLC22A6 (0.92) | SLC22A6LMNAHDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312299-B2 | Bioabsorbabl, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-12-25 | — | — | US | claimed |
| US-7301001-B2 | Bioabsorbable, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-11-27 | — | — | US | claimed |
| US-20070123689-A1 | Bioabsorbable, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-05-31 | — | — | US | claimed |
| US-20070100123-A1 | Bioabsorbable, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-05-03 | — | — | US | claimed |
| US-7186789-B2 | Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-03-06 | — | — | US | claimed |
| JP-2007501893-A | — | — | 2007-02-01 | — | — | JP | claimed |
| EP-1636290-A1 | BIOABSORBABLE, BIOBENEFICIAL POLYESTER POLYMERS FOR USE IN DRUG ELUTING STENT COATINGS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-03-22 | — | — | EP | claimed |
| WO-2005000939-A1 | BIOABSORBABLE, BIOBENEFICIAL POLYESTER POLYMERS FOR USE IN DRUG ELUTING STENT COATINGS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2005-01-06 | — | — | WO | claimed |
| US-20040253203-A1 | Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2004-12-16 | — | — | US | claimed |
| US-7312299-B2 | Bioabsorbabl, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-7301001-B2 | Bioabsorbable, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-11-27 | — | — | US | disclosed |
| US-20070123689-A1 | Bioabsorbable, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-05-31 | — | — | US | disclosed |
| US-20070100123-A1 | Bioabsorbable, biobeneficial polyester polymers for stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-05-03 | — | — | US | disclosed |
| US-7186789-B2 | Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-03-06 | — | — | US | disclosed |
| EP-1636290-A1 | BIOABSORBABLE, BIOBENEFICIAL POLYESTER POLYMERS FOR USE IN DRUG ELUTING STENT COATINGS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-03-22 | — | — | EP | disclosed |
| WO-2005000939-A1 | BIOABSORBABLE, BIOBENEFICIAL POLYESTER POLYMERS FOR USE IN DRUG ELUTING STENT COATINGS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| US-20040253203-A1 | Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2004-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040253203-A1 | Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings | CEL, CD44, PBDC1 | SLC22A6 1112/4885LMNA 4119/4885HDAC3 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.